The luxury hospitality world’s premier gathering dazzles with dynamic speakers, memorable performances and a few surprises.
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially landscape-changing combinations.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback